We are live on ! Find out more
RAM

Redmond Asset Management Portfolio holdings

AUM $366M
1-Year Est. Return 10.64%
This Fund
S&P 500
This Quarter Est. Return
+13.86%
1 Year Est. Return
+10.64%
3 Year Est. Return
+59.08%
5 Year Est. Return
+69.06%
10 Year Est. Return
+374.78%
AUM
$310M
AUM Growth
+$29.6M
Cap. Flow
-$4.2M
Cap. Flow %
-1.35%
Top 10 Hldgs %
24.51%
Holding
162
New
2
Increased
41
Reduced
88
Closed
4

Top Buys

Rank Stock Value
1
PODD icon
Insulet
PODD
+$2.09M
2
PEP icon
PepsiCo
PEP
+$1.32M
3
BLKB icon
Blackbaud
BLKB
+$1.2M
4
BTBT icon
Bit Digital
BTBT
+$708K
5
APLD icon
Applied Digital
APLD
+$646K

Top Sells

Rank Stock Value
1
WSO icon
Watsco Inc
WSO
+$833K
2
AMAT icon
Applied Materials
AMAT
+$816K
3
CCI icon
Crown Castle
CCI
+$787K
4
TPL icon
Texas Pacific Land
TPL
+$720K
5
XPO icon
XPO
XPO
+$551K

Sector Composition

Rank Sector Weight
1 Technology 24.31%
2 Industrials 21.1%
3 Financials 18.3%
4 Healthcare 8.18%
5 Communication Services 8.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PG icon
101
Procter & Gamble
PG
$339B
$973K 0.31%
6,639
+1
+0% +$148
MEDP icon
102
Medpace
MEDP
$16.5B
$966K 0.31%
3,150
-297
-9% -$80.2K
SLP icon
103
Simulations Plus
SLP
$371M
$955K 0.31%
21,330
-597
-3% -$23.7K
PGNY icon
104
Progyny
PGNY
$2.2B
$888K 0.29%
23,873
-477
-2% -$16K
JBTM
105
JBT Marel
JBTM
$6.39B
$875K 0.28%
8,794
FORM icon
106
FormFactor
FORM
$9.17B
$871K 0.28%
20,889
-602
-3% -$22K
BDX icon
107
Becton Dickinson
BDX
$48.7B
$847K 0.27%
3,475
-88
-2% -$21.7K
PYPL icon
108
PayPal
PYPL
$50.5B
$826K 0.27%
13,458
-4,031
-23% -$231K
KEYS icon
109
Keysight
KEYS
$58.3B
$791K 0.26%
4,972
BCTX
110
Briacell Therapeutics
BCTX
$31.7M
$781K 0.25%
890
-29
-3% -$20.8K
VT icon
111
Vanguard Total World Stock ETF
VT
$79.8B
$762K 0.25%
7,410
XOM icon
112
ExxonMobil
XOM
$634B
$705K 0.23%
7,054
-50
-0.7% -$5.25K
STAA icon
113
STAAR Surgical
STAA
$1.21B
$685K 0.22%
21,942
-295
-1% -$10.6K
OMCL icon
114
Omnicell
OMCL
$1.68B
$678K 0.22%
18,018
-290
-2% -$10.7K
GWRS icon
115
Global Water Resources
GWRS
$219M
$643K 0.21%
49,174
ANVS icon
116
Annovis Bio
ANVS
$80M
$637K 0.21%
34,080
IVV icon
117
iShares Core S&P 500 ETF
IVV
$902B
$634K 0.2%
1,327
-465
-26% -$208K
WTS icon
118
Watts Water Technologies
WTS
$13.1B
$627K 0.2%
3,010
-83
-3% -$15.7K
WRAP icon
119
Wrap Technologies
WRAP
$104M
$577K 0.19%
186,226
-19,008
-9% -$43.3K
LEA icon
120
Lear
LEA
$8.18B
$541K 0.17%
3,830
-155
-4% -$20.8K
HGTY icon
121
Hagerty
HGTY
$1.39B
$540K 0.17%
69,285
-14,618
-17% -$119K
MDT icon
122
Medtronic
MDT
$112B
$538K 0.17%
6,532
-259
-4% -$19.7K
BIPC icon
123
Brookfield Infrastructure
BIPC
$4.85B
$524K 0.17%
14,862
+6,909
+87% +$220K
INTC icon
124
Intel
INTC
$513B
$508K 0.16%
10,118
+1,625
+19% +$66K
VEA icon
125
Vanguard FTSE Developed Markets ETF
VEA
$236B
$487K 0.16%
10,173
+774
+8% +$34.6K

Similar funds

Redmond Asset Management's Q4 2023 Portfolio in Review

As of Q4 2023, Redmond Asset Management held 162 positions worth $310M, up 11% from $281M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Trading was light in Q4 2023: portfolio turnover was 3.7%. Redmond Asset Management opened 2 new positions and exited 4, leaving the 162-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Industrials and Financials.

  • Redmond Asset Management's largest Q4 2023 buy was Insulet: 12,206 shares worth $2.65M.
  • Redmond Asset Management added most to PepsiCo in Q4 2023, an estimated $1.32M increase.
  • Redmond Asset Management's biggest Q4 2023 reduction was Watsco Inc, cutting an estimated $833K.
  • Redmond Asset Management fully exited Texas Pacific Land in Q4 2023, selling an estimated $720K.
  • Redmond Asset Management's ten largest holdings make up 25% of its $310M portfolio in Q4 2023.
  • Redmond Asset Management opened 2 new positions and closed 4 in Q4 2023.
  • Redmond Asset Management's portfolio value rose 11% quarter-over-quarter to $310M.

Based on Redmond Asset Management's 13F filing for Q4 2023, filed 12 Feb 2024.